
Pancham Bakshi
Examiner (ID: 13798, Phone: (571)270-3463 , Office: P/1671 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1621, 1671, 1623, 1673 |
| Total Applications | 1518 |
| Issued Applications | 1042 |
| Pending Applications | 137 |
| Abandoned Applications | 365 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18374361
[patent_doc_number] => 20230149440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => OPHTHALMIC LIQUID COMPOSITION COMPRISING LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID
[patent_app_type] => utility
[patent_app_number] => 17/918652
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918652 | OPHTHALMIC LIQUID COMPOSITION COMPRISING LOW MOLECULAR WEIGHT LINEAR HYALURONIC ACID | Apr 15, 2021 | Abandoned |
Array
(
[id] => 17005365
[patent_doc_number] => 20210236526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/231336
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15531
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231336 | IMMUNOMODULATORY OLIGOSACCHARIDES | Apr 14, 2021 | Abandoned |
Array
(
[id] => 17005366
[patent_doc_number] => 20210236527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 17/231367
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231367
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231367 | IMMUNOMODULATORY OLIGOSACCHARIDES | Apr 14, 2021 | Abandoned |
Array
(
[id] => 18603372
[patent_doc_number] => 11744812
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Methods of treatment
[patent_app_type] => utility
[patent_app_number] => 17/231716
[patent_app_country] => US
[patent_app_date] => 2021-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38979
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231716
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/231716 | Methods of treatment | Apr 14, 2021 | Issued |
Array
(
[id] => 16991958
[patent_doc_number] => 20210230378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => GEL COMPOSITION AND PRODUCTION METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/229978
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229978
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/229978 | Gel composition and production method therefor | Apr 13, 2021 | Issued |
Array
(
[id] => 18483590
[patent_doc_number] => 20230210890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => COMPOSITIONS AND METHODS OF TREATING COVID-19 WITH HEPARIN OR OTHER NEGATIVELY CHARGED MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/996086
[patent_app_country] => US
[patent_app_date] => 2021-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8702
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996086
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996086 | COMPOSITIONS AND METHODS OF TREATING COVID-19 WITH HEPARIN OR OTHER NEGATIVELY CHARGED MOLECULES | Apr 12, 2021 | Pending |
Array
(
[id] => 16976076
[patent_doc_number] => 20210220313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => FORMULATION AND METHOD FOR THE PREVENTION AND/OR TREATMENT OF HANGOVER SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 17/227020
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/227020 | Formulation and method for the prevention and/or treatment of hangover symptoms | Apr 8, 2021 | Issued |
Array
(
[id] => 19431425
[patent_doc_number] => 20240299923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => HYDROGENATION CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/548448
[patent_app_country] => US
[patent_app_date] => 2021-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548448
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/548448 | HYDROGENATION CATALYST, PREPARATION METHOD THEREFOR AND USE THEREOF | Apr 8, 2021 | Pending |
Array
(
[id] => 18525465
[patent_doc_number] => 11712443
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors
[patent_app_type] => utility
[patent_app_number] => 17/223776
[patent_app_country] => US
[patent_app_date] => 2021-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 27
[patent_no_of_words] => 18400
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223776
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/223776 | 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors | Apr 5, 2021 | Issued |
Array
(
[id] => 17370388
[patent_doc_number] => 20220025440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => LABELLING COMPOUNDS AND THEIR USE IN ASSAYS
[patent_app_type] => utility
[patent_app_number] => 17/222484
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222484
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222484 | Labelling compounds and their use in assays | Apr 4, 2021 | Issued |
Array
(
[id] => 19127173
[patent_doc_number] => 20240132526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => PREPARATION METHOD FOR TRIMETHYLALUMINUM
[patent_app_type] => utility
[patent_app_number] => 18/546323
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546323
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546323 | PREPARATION METHOD FOR TRIMETHYLALUMINUM | Apr 1, 2021 | Pending |
Array
(
[id] => 17156095
[patent_doc_number] => 20210317146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA
[patent_app_type] => utility
[patent_app_number] => 17/221463
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -45
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221463
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221463 | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia | Apr 1, 2021 | Issued |
Array
(
[id] => 18391362
[patent_doc_number] => 20230159580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODECA-1,3(7),5,8,11-PENTAENE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)
[patent_app_type] => utility
[patent_app_number] => 17/916481
[patent_app_country] => US
[patent_app_date] => 2021-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916481
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/916481 | PYRROLO[2,3-F]INDAZOLE AND 2,4,5,10-TETRAZATRICYCLO[7.3.0.03,7]DODECA-1,3(7),5,8,11-PENTAENE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD) | Apr 1, 2021 | Pending |
Array
(
[id] => 19127173
[patent_doc_number] => 20240132526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-25
[patent_title] => PREPARATION METHOD FOR TRIMETHYLALUMINUM
[patent_app_type] => utility
[patent_app_number] => 18/546323
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546323
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546323 | PREPARATION METHOD FOR TRIMETHYLALUMINUM | Mar 31, 2021 | Pending |
Array
(
[id] => 20240970
[patent_doc_number] => 12421278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-23
[patent_title] => Immunomodulators
[patent_app_type] => utility
[patent_app_number] => 17/995196
[patent_app_country] => US
[patent_app_date] => 2021-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4047
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995196
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995196 | Immunomodulators | Mar 29, 2021 | Issued |
Array
(
[id] => 17126631
[patent_doc_number] => 20210301400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => PRECURSORS AND METHODS FOR PREPARING SILICON-CONTAINING FILMS
[patent_app_type] => utility
[patent_app_number] => 17/214701
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214701 | Precursors and methods for preparing silicon-containing films | Mar 25, 2021 | Issued |
Array
(
[id] => 18420116
[patent_doc_number] => 20230174577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/912647
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912647
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912647 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | Mar 24, 2021 | Issued |
Array
(
[id] => 16948095
[patent_doc_number] => 20210206786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => N-ALKYL SUBSTITUTED CYCLIC AND OLIGOMERIC PERHYDRIDOSILAZANES, METHODS OF PREPARATION THEREOF, AND SILICON NITRIDE FILMS FORMED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 17/210652
[patent_app_country] => US
[patent_app_date] => 2021-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210652
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210652 | N-alkyl substituted cyclic and oligomeric perhydridosilazanes, methods of preparation thereof, and silicon nitride films formed therefrom | Mar 23, 2021 | Issued |
Array
(
[id] => 18374204
[patent_doc_number] => 20230149281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => PEPTIDE COMPOSITION AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 17/917416
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917416
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917416 | PEPTIDE COMPOSITION AND METHOD FOR PRODUCING SAME | Mar 21, 2021 | Pending |
Array
(
[id] => 20993358
[patent_doc_number] => 12741978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-09-22
[patent_title] => Zinc compound, thin-film forming raw material, thin-film, and method of producing thin-film
[patent_app_type] => utility
[patent_app_number] => 17/915300
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5599
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915300 | ZINC COMPOUND, THIN-FILM FORMING RAW MATERIAL, THIN-FILM, AND METHOD OF PRODUCING THIN-FILM | Mar 17, 2021 | Pending |